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Cutaneous innervation is increasingly recognized as a major element of skin physiopathology through the
neurogenic inflammation driven by neuropeptides that are sensed by endothelial cells and the immune
system. To investigate this process in vitro, models of innervated tissue-engineered skin (TES) were
developed, yet exclusively with murine sensory neurons extracted from dorsal root ganglions. In order
to build a fully human model of innervated TES, we used induced pluripotent stem cells (iPSC) generated
from human skin fibroblasts. Nearly 100% of the iPSC differentiated into sensory neurons were shown to
express the neuronal markers BRN3A and b3-tubulin after 19 days of maturation. In addition, these cells
were also positive to TRPV1 and neurofilament M, and some of them expressed Substance P, TrkA and
TRPA1. When stimulated with molecules inducing neuropeptide release, iPSC-derived neurons released
Substance P and CGRP, both in conventional monolayer culture and after seeding in a 3D fibroblast-
populated collagen sponge model. Schwann cells, the essential partners of neurons for function and axo-
nal migration, were also successfully differentiated from human iPSC as shown by their expression of the
markers S100, GFAP, p75 and SOX10. When cultured for one additional month in the TES model, iPSC-
derived neurons seeded at the bottom of the sponge formed a network of neurites spanning the whole
TES up to the epidermis, but only when combined with mouse or iPSC-derived Schwann cells. This unique
model of human innervated TES should be highly useful for the study of cutaneous neuroinflammation.
Statement of Significance
The purpose of this work was to develop in vitro an innovative fully human tissue-engineered skin
enabling the investigation of the influence of cutaneous innervation on skin pathophysiology. To reach
that aim, neurons were differentiated from human induced pluripotent stem cells (iPSCs) generated from
normal human skin fibroblasts. This innervated tissue-engineered skin model will be the first one to
show iPSC-derived neurons can be successfully used to build a 3D nerve network in vitro. Since innerva-
tion has been recently recognized to play a central role in many human skin diseases, such as psoriasis
and atopic dermatitis, this construct promises to be at the forefront to model these diseases while using
patient-derived cells.
 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Although the primary purpose of cutaneous sensory innervation
is the perception of sense of touch, pain and temperature, it also
plays a major role in skin physiology and pathology. Indeed, sen-
sory neurons are able to trigger a neurogenic inflammation upon
stimulation through the release of neuropeptides. This process
induces microvascular vasodilation and an increase in vascular
permeability, along with immune cells chemotaxis and activation
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the local innate immune response early after an injury to promote
tissue inflammation. Moreover, it has more recently been shown
that sensory neurons are also involved in the direct recognition
of pathogens through the same molecular pathways as immune
cells, such as Toll Like Receptors (TLRs) [2]. The density of cuta-
neous innervation as well as the high speed of neural action poten-
tials constitute major advantages for the detection of danger
signals. Thus, the in vitro development of a human skin integrating
a nerve network represents an essential first step towards detailed
studies on the interaction of nociceptor neurons with endothelial
and immune cells and the regulation of neurogenic inflammation.
We previously created an innervated TES including sensory neu-
rons obtained from mouse embryos. These neurons were cultured
underneath the tissue and were shown to build a dense nerve net-
work that reached the epidermis through the whole thickness of
the dermal compartment [3,4]. Neurons released neuropeptides
such as SP that was shown to enhance reepithelialization in an
in vitro model of wound healing [5]. Whereas murine neuropep-
tides successfully activated human cells, their animal origin in a
human tissue-engineered skin model could be a limitation for fur-
ther studies, all the more that dorsal root ganglion neurons are
extracted at an early embryonic developmental stage (E12 to
E14). To develop a more reliable innervated skin model, the use
of human sensory neurons is highly desirable, especially for cos-
metic research and development in Europe where the use of ani-
mal cells is banned.
Fortunately, the technology allowing the differentiation of neu-
ronal cells from human skin fibroblasts induced to become
pluripotent stem cells (iPSC) is now widely available [6].
Some research groups succeeded in differentiating iPSC into
sensory neurons, albeit with low degrees of purity and cell yields,
and these studies did not attempt to create tridimensional net-
works [7–14]. To study neurogenic inflammation, it is crucial that
the sensory neurons differentiated from human iPS cells express
the transient receptor potential cation channel subfamily (TRPV1,
TRPV2, TRPV3, TRPA1) that regulate neuropeptides release [15].
Indeed, a challenge with hot temperature or irritant compounds
like capsaicin or eugenol should drive activation of TRPVs and sub-
sequent release of neuropeptides, mainly Substance P (SP) and Cal-
citonin gene-related peptide (CGRP), from peptidergic sensory
neurons. Moreover, sensory neurons should express the tropomyo-
sin receptor kinase A (TRKA) responsible for the binding to nerve
growth factor (NGF), necessary for their survival [12].
Here, we propose a complete method to differentiate pure,
functional sensory neurons and Schwann cells from human iPSCs
and their combination in a 3D culture system to generate a fully
human tissue-engineered skin model. It will be a highly valuable
tool to study in vitro the relationship between human sensory
nerves and skin physiopathology.2. Materials and methods
2.1. Cell culture
All human cells used in this work were obtained with informed
consent from the donors; The study was approved by the CHU de
Quebec-Université Laval research ethics review board.
Fibroblasts and keratinocytes were isolated from human skin
biopsies after breast reductive surgeries as previously described
[16].
Human keratinocytes were cultured in flasks on a feeder layer
of irradiated 3T3 mouse fibroblasts in DHc medium consisting
of a 3:1 ratio of DMEM/Ham’s F12 (Gibco, Gaithersburg, MD) with
36.54 mMNaHCO3 (J.T. Baker, Phillipsburg, NJ), 0.18 mM L-adenine(Millipore Sigma, Oakville, Canada), 312.5 ll/l 2 N HCL (Fisher
Scientific, Ottawa, Canada) and supplemented with 5% HyClone
FetalClone II (Hyclone, Logan, UT), 2.5 lg/mL insulin (Millipore
Sigma), 0.2 lg/mL hydrocortisone (Millipore Sigma), 1010 M
cholera toxin (ICN Biochemicals, Costa Mesa, CA), 10 ng/mL human
epidermal growth factor (Austral Biologicals, San Ramon, CA), and
antibiotics.
Human microvascular endothelial cells were extracted from
foreskin as previously described [17] and grown in endothelial
growth medium EBM-2 (Lonza, Mississauga, Canada).
Mouse DRG were extracted from E12.5 mice as previously
described [3] and cultured in DME medium (Gibco) supplemented
with 10% fetal bovine serum (FBS) (Wisent, St-Bruno, Canada) and
with 10 ng/mL NGF (Sino Biological, Atlanta, GA), and were
cultured in same conditions as iPS-derived neurons to serve as
controls. All animal experiments were approved by the CHU de
Quebec-Université Laval animal care committee following the
guidelines of the Canadian Council on Animal Care.
2.2. Differentiation of iPS cells into sensory neurons:
The iPS cells were obtained from the iPS-Quebec platform of the
CHU de Québec-Université Laval research center. They were
derived from 2 different human skin fibroblast cell lines and from
one human peripheral blood mononuclear cell line. The iPS cells
were reprogrammed with the CytoTuneTM-iPS 2.0 Sendai Repro-
gramming Kit (Invitrogen, Carlsbad, California).
Differentiation into sensory neurons was performed following a
protocol modified from reference [14]: iPS cells were passagedwith
Stempro accutase (Gibco) added with 5 mM Y-27632 (Abcam,
Toronto, Canada), diluted in DMEM-F12 medium containing
25 lg/ml of penicillin-gentamycin (Sigma Chemicals) without
serum. Cells were plated on Geltrex (Gibco) coating (1:200 dilution)
in a 6 wells plate at a density of 90,000 cells/cm2 and passaged at
confluency with Stempro accutase and 5 mM Y-27632. From day 0
to day 11 of differentiation, cells were cultured in a DMEM
F12 : neurobasal A medium (Gibco) (vol:vol) supplemented
with 2% B-27 (Gibco), 1% N2 supplement (Gibco), 0.01 mM
b-mercaptoethanol (Gibco), 50 mg/mL ascorbic acid (Sigma
Millipore), 5 mM Y-27632, 1% L-alanyl-L-glutamine (Corning,
New-York, NY), 1% MEM non-essential amino acids (Gibco), 0.1%
trace elements A, 0,1% trace elements B, 0,1% trace elements C
(Corning). From day 0 to day 5 of differentiation, medium was sup-
plemented with 40 mM SB431542, 0.2 mM LDN193189 and 3 mM
CHIR99021 (Sigma Millipore). From day 5 to day 7 of differentia-
tion, medium was supplemented with 3 mM CHIR99021. From day
9 to day 11 of differentiation, medium was supplemented with
10 mM DAPT (Selleck Chemicals LLC, Houston, TX). At day 11, cells
were passaged with Stempro accutase and 5 mM Y-27632 and pla-
ted on 1 mg/ml Poly-D-lysine (Sigma Millipore) coated wells for 2D
tests. Cells were seeded at 300,000 cells/cm2 for purity tests, at
600,000 cells/cm2 per well for ELISA tests and at 106 cells/3.6 cm2
when seeded over the 3D sponge model. For the quantification of
the sensory neuron purity, cells were seeded on poly-D-lysine
surface in a 24-wells plate and the ratio of b3Tub/BRN3A positive
cells versus the number of unstained but Dapi-positive cells at
day 18 was quantified using an axio imager M2 microscope (Zeiss,
Toronto, Canada). Experiment was done in sextuplicates and 6
fields per well were evaluated using a 40x lens.
2.3. Differentiation of iPS cells into Schwann cells.
Differentiation of iPSC into Schwann cells was performed fol-
lowing a protocol modified from reference [18]. Up to day 6, iPS
cells were cultured in the same conditions than for sensory neuron
differentiation in order to reach a neuronal precursor commitment.
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5 mM Y-27632 and plated on a 9.6 cm2 Geltrex coated well
(1:200 dilution in cold DH medium) at a density of 130,000 cells/
cm2 in the day 7 medium from sensory neuron differentiation. At
day 7, cells were cultured in minimum essential medium (STEM-
CELL Technologies, Vancouver, Canada) with 1% N2 supplement,
1 mM b-mercaptoethanol, 5 mM Y-27632, 1% L-alanyl-L-glutamine,
1% MEM non-essential amino acids (Gibco), 0.1% trace elements
A, 0.1% trace elements B, 0.1% trace elements C. From day 8 to
day 11, b-mercaptoethanol was removed and 35 ng/ml retinoic
acid (Sigma Millipore) was added to the medium with 1% B27 sup-
plement without vitamin A. At day 12, cells were passaged with
accutase and plate on 1 mg/ml Poly-D-lysine coated well at a den-
sity of 50,000 cells/cm2. From day 12 to day 26, cells were cultured
in STEMdiff Apel medium (STEMCELL Technologies) supplemented
with 1% N2 supplement, 1% B27 supplement without vitamin A,
5 mM Y-27632, 5 mM Y-27632, 1% L-alanyl-L-glutamine, 1% MEM
non-essential amino acids, 0.1% trace elements A, 0.1% trace
elements B, 0.1% trace elements C, 5 ng/ml PDGF-bb, (Gibco),
10 ng/ml bFGF (Feldan, Quebec City, Canada), 14 mM forskolin
(Sigma Millipore), 192 ng/ml NRG1 (R&D System, Oakville,
Canada). From day 26 until the end of the 2D culture, Schwann
cells were maintained in DH medium supplemented with 10%
FBS, 5 mM forskolin, 50 ng/ml NRG1, 1% N2 supplement, 1%
L-alanyl-L-glutamine. Schwann cells were cultured with 0.25 nM
goat anti-rabbit IgG (Electron microscopy sciences, Hatfield, PA)
for 3 days before seeding cells on sponges [19]. For 2D coculture
(Fig. 3D,H), 300,000 iPS Schwann cells were seeded with 600,00
iPS sensory neurons in 24-well plates. Cells were maintained in
DMEM F12 : neurobasal A medium (vol:vol) supplemented with
1% B-27, 1% N2 supplement, 50 mg/mL ascorbic acid, 1% L-alanyl-
L-glutamine, 20 ng/mL BDNF (Sino Biological), 10 ng/mL GDNF
(Sino Biological) and 10 ng/mL NGF, 0.2 lg ml1 hydrocortisone,
2.5 lg ml1 insulin. Cells were cultivated 18 days before fixation.
2.4. Cell purity quantification
To quantify the proportion of iPS cells effectively differentiated
into sensory neurons, neurons at day 11 were seeded at a density
of 300,000 cells/cm2 in 24-wells plates on poly-D-lysine surface
(n = 6) and cultured as previously described for 7 days. Cells were
fixed with PFA 4% and cell purity was assessed using a Zeiss axio
imager M2 microscope. Purity was determined by quantification
of the ratio of b3Tub/BRN3A positive cells compared to the number
of Dapi-positive cells (Supplemental Fig. S2). For each well, 6 fields
were evaluated using a 40x lens. The same method was performed
for assessing Schwann cell purity by calculating the ratio of S100-
positive cells over the number of Dapi-positive cells.
2.5. Preparation of the tissue-engineered 3D skin model
Collagen sponges were prepared as previously described [20]
and seeded with 800,000 human fibroblasts alone (for ELISA tests)
or in combination with 800,000 endothelial cells (for all other con-
ditions) and cultured in DME (Life Technologies) supplemented
with 10% fetal calf serum (FCS) mixed 1:1 (vol:vol) with EBM2
(Lonza, Mississauga, Canada) and 50 mg/mL ascorbic acid for
7 days. Then, 400,000 fibroblasts (for ELISA tests) or in combina-
tion with 400,000 endothelial cells (for all other conditions) were
seeded on the opposite side of the sponge. After 3 days, Schwann
cells from mouse sciatic nerves [20] or derived from human iPSC
were seeded (only when specified) at a density of 1 million per
sponge on top of the sponge. All samples (with or without Sch-
wann cells) were cultured for 7 days in DMEM-F12 medium sup-
plemented with 10% FBS, 5 mM forskolin, 50 ng/ml NRG1, 1% N2
supplement, 1% L-alanyl-L-glutamine.One million of iPS-derived sensory neurons matured for 11 days
were then seeded on the opposite side (versus Schwann cells) of
the sponge and cultured for two days in DMEM F12:neurobasal A
medium (vol:vol), supplemented with 1% B-27, 1% N2 supplement,
50 mg/mL ascorbic acid, 5 mM Y-27632, 10 mM DAPT, 20 ng/mL
BDNF (Feldan) and 10 ng/mL GDNF. The sponge was matured 6
additional days in DMEM F12, neurobasal A medium vol:vol, sup-
plemented with 1% B-27, 1% N2 supplement, 50 mg/mL ascorbic
acid, 5 mM Y-27632, 20 ng/mL BDNF (Sino Biological), 10 ng/mL
GDNF (Sino Biological) and 10 ng/mL NGF.
Sponges were flipped upside down and 1 million of human ker-
atinocytes were seeded on top of sponge (opposite side to neurons)
under immersion in the culture medium. Samples were cultured
7 days in DMEM-F12 with 5% Hyclone serum supplemented with
20 ng/mL BDNF (Feldan), 10 ng/mL GDNF, 10 ng/mL NGF,
50 mg/mL ascorbic acid, 0.2 lg ml1 hydrocortisone, 2.5 lg ml1
insulin, 10 ng/mL human epidermal growth factor and 1010 M
cholera toxin. Then, sponges were lifted up at air–liquid interface
to promote keratinocyte differentiation for 17 days in the same
medium but without EGF.
2.6. ELISA analyses
To quantify SP and CGRP secretion with Elisa kit (Phoenix Phar-
maceuticals), sensory neurons differentiated from iPSC or
extracted from mouse DRG were seeded at a density of 600,000
and 300,000 cells/cm2 respectively in 24-well plates coated with
poly-D-lysine. For ELISA quantification of the 3D tissue super-
natants, sponges were seeded with 1 million sensory neurons
derived from iPS or from DRG and were washed twice with
DMEM-F12 without serum before treatment. For 2D or 3D tests,
medium was replaced with 150 ml or 400 ml of DMEM-F12:
Neurobasal A medium (vol:vol) pH 6.2, respectively. Capsaicin
(Sigma Millipore) was dissolved in ethanol 99% for a final concen-
tration of 10 mM. Cells were exposed with capsaicin or KCl (Fisher
Chemical, Ottawa, Canada) for 5 min or with AITC (Sigma-
Millipore), eugenol (Sigma Millipore) or NGF for 10 min before
removing the supernatant for Elisa tests or fixation with PFA 4%
for immunostaining.
2.7. Immunofluorescence
Cells were fixed with 4% cold PFA for 20 min at 4 C, washed
twice with cold phosphate-buffered saline (PBS) (composed of
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4)
(Fisher Chemical), then incubated in immunofluorescence staining
buffer, containing PBS, 0.3% triton X-100 (Biorad, Mississauga,
Canada) and 5% serum, for 20 min at room temperature. Cells were
stained overnight at 4 C with primary antibodies diluted in
immunofluorescence staining buffer and were washed with PBS
for 5 min then incubated for 1 h at room temperature with sec-
ondary antibodies (1:500 dilution) in immunofluorescence stain-
ing buffer and finally were washed with PBS before mounting
with fluoromount G with Dapi (Electron microscopy Sciences, Hat-
field, PA).
The antibodies used were: mouse anti-b3Tub (1:1000; Biole-
gend, San Diego, CA), rabbit anti-BRN3A (1:500; Millipore Sigma),
mouse anti-substance P (1:1000; Abcam), goat anti-TRKA (1:200;
R&D System), rabbit anti-TRPA1 (1:200; Abcam), sheep anti-
TRPM8 (1:100; Novus Biologicals, Oakville, Canada), mouse or
chicken anti-NFM and anti-NFH (1:500; Millipore Sigma), rabbit
anti-TRPV1 (1:200; Novus Biologicals), goat anti-RAMP1 (1:50;
Santa Cruz, Mississauga, Canada), rabbit anti-P75 (1:200; Abcam),
rabbit or mouse anti-S100 (DAKO cytomation, Santa Clara, CA),
mouse anti-MBP (1:500; R&D System), mouse anti-SOX10
(1:500; R&D System), mouse anti-GFAP (1:500; Millipore Sigma),
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(1:500; Invitrogen), Alexa fluor 594 goat anti-mouse (1:500; Invit-
rogen), Alexa fluor 594 goat anti-rabbit (1:500; Invitrogen), Alexa
fluor 488 goat anti-mouse (1:500; Invitrogen), Alexa fluor 647 don-
key anti-sheep (1:500; Invitrogen), Alexa fluor 647 or 488 donkey
anti-chicken (1:500; Invitrogen), Alexa fluor 555 donkey anti-
mouse (1:500; Invitrogen), Alexa fluor 488 donkey anti-rabbit
(1:500; Invitrogen).2.8. Statistical analysis
Statistical analyses were performed using one-way ANOVA.
Post-Hoc test were conducted using Bonferroni correction
(a = 0.05). The differences were considered significant at p < 0.05.
Results were expressed as mean ± standard error of the mean
(SEM).3. Results
3.1. Sensory neurons were differentiated from human iPS cells with
high purity, high yield and expressed specific markers
Human fibroblasts-derived iPSCs cultured on Geltrex-coated 6-
well plates (2D culture) were allowed to differentiate for 22 days
and were stained with specific markers for sensory neurons to con-
firm their identity. Based on the expression of BRN3A (a transcrip-
tion factor expressed in the developing sensory neurons [21,22],
neurofilament M (NFM, 150 kDa [23]) and TRPV1, the optimal mat-
uration time was observed at day 19, and was followed by a
decrease in the number of cells at day 22 (Supplemental
Fig. S1A-O). Mouse dorsal root ganglion (DRG)-derived sensory
neurons expressed the same markers in a similar pattern (Supple-
mental Fig. S1P-R).
To determine the proportion of iPS-derived cells that were effi-
ciently differentiated into sensory neurons, cells were double-
stained for BRN3A, and b3Tub (staining for bIII-tubulin, a generic
marker of neurons [24]). Immunfluorescence images showed that
nearly 100% (98.9% ± 1.35, n = 6) of cells were positive for both
markers (Supplemental Fig. S2). Over the whole maturation period,
iPSC growth resulted in a 65 ± 15-fold increase (n = 10) in the num-
ber of cells differentiated into sensory neurons, as compared to the
initial number of iPSC seeded. This high yield, as compared to the
original protocol by Maury et al. [14] might be explained at least
in part by a more potent growth of cells as monolayer culture
instead of neurospheres. Moreover, the culture medium was sup-
plemented by additional nutrients. And accutase, a mild digestive
enzyme, was used instead of trypsin, allowing a more efficient cell
recovery for cell harvesting/replating.
At day 19, in addition to BRN3A and b3Tub, some of the differ-
entiated cells expressed the neurofilament M and SP. In addition,
most cells were positive to TRPV1 and TRPA1, with some of them
expressing TrkA (the receptor for NGF) (Fig. 1A,C,E,G).
To incorporate the iPSC-derived neurons into the 3D model, it
was not possible to first fully differentiate the neurons in 2D for
19 days, and then seed them over the sponge. Indeed, since mature
neurons already displayed long neurites at day 19, their enzymatic
digestion induced massive cell death precluding their use for 3D
seeding. To overcome this limitation, iPSC-derived neurons were
passaged with accutase at day 11 of differentiation (before neurite
outgrowth) and seeded on the sponge 3D model. To confirm that
the differentiation of the sensory neurons between day 11 and
day 19 was as efficient in 3D as in 2D, the expression of neuronal
markers was assessed by immunofluorescent staining of whole
sponges, followed by en-face imaging. A similar pattern ofexpression of the markers BRN3A, b3Tub, SP, NFM, TrkA and TRPA1
was observed, along with Ramp1 (a CGRP receptor) (Fig. 1B,D,F,H).
In addition, since these neurons can be maintained in 3D cul-
ture for a much longer time, numerous nerve fibers were observed
after 49 days of culture to express the neurofilament H (200 kDa),
which is a marker of larger caliber and more mature axons [25]. In
addition, most of these NFH-positive fibers also expressed SP
(Supplemental Fig. S3).
Interestingly, iPSC-derived neurons showed a tendency to
aggregate together into ganglion-like clusters from which large
bundles of neurites elongated, in contrast with mouse DRG neu-
rons that were homogeneously distributed beneath the sponge
(Fig. 1I,J). Of note, a similar cluster formation was reported with
iPSC-derived sensory neurons cultured in 2D after 2 weeks in cul-
ture [26]. The non-peptidergic marker P2X3 was not detected in 2D
and 3D cultures (Data not shown).
3.2. TRP agonists trigger SP and CGRP release from iPSC-derived
sensory neurons
In order to test the capacity of the iPSC-derived sensory neurons
to induce neurogenic inflammation, their potential to release neu-
ropeptides upon TRPV activation was investigated and compared
to mouse DRG neurons in conventional 2D culture as well as in
3D culture into the sponge (only populated with fibroblasts).
The TRPV1 agonists resiniferatoxin (at 100 nM) induced a sig-
nificant increase in the release of SP from iPSC-derived neurons
cultured in 2D compared to control (p < 0.0001; n = 13), while
the effect of capsaicin (at 10 mM) was not significant (Fig. 2A).
Moreover, eugenol (at 1 mM), an agonist of TRPV1, 2 and 3 induced
a significant increase of SP release (p < 0.0001; n = 14), as well as
NGF (at 100 ng/ml), the agonist of TrkA (p < 0.01; n = 16). KCl (at
65 mM), which induces neuronal depolarization independently of
receptors, promoted the most potent rise of SP release
(p < 0.0001; n = 16) (Fig. 2A). Of note, although TRPA1 was
detected by immunofluorescence staining, exposure to its agonist
AITC (300 mM) did not result in a significant difference of SP secre-
tion. As a control, 2D culture of mouse DRG neurons showed signif-
icant increases of SP release upon stimulation with capsaicin
(p < 0.0001; n = 5), resiniferatoxin (p < 0.0001; n = 6), eugenol
(p < 0.01; n = 6) and treatment with KCL (p < 0.0001; n = 6)
(Fig. 2B).
When cultured in 3D in a fibroblast-populated sponge, iPSC-
derived neurons released significantly higher amount of SP after
stimulation with capsaicin (p < 0.0001; n = 17) and KCl
(p < 0.001; n = 16), while resiniferatoxin, AITC and NGF did not
have an effect (Fig. 2C). Stimulation of mouse DRG neurons in
the same 3D culture scaffold produced significantly higher levels
of SP upon treatment with capsaicin (p < 0.01; n = 6), resinifera-
toxin (p < 0.001; n = 5) and KCl (p < 0.0001; n = 7) (Fig. 2D).
The secretion of CGRP by iPSC-derived neurons was signifi-
cantly enhanced by eugenol (p < 0.0001; n = 18), AITC (p < 0.001;
n = 18), NGF (p < 0.001; n = 18) and KCl (p < 0.01; n = 18) in 2D cul-
ture (Fig. 2E), and by eugenol (p < 0.0001; n = 11) and KCl
(p < 0.001; n = 17) in 3D sponges (Fig. 2G). Mouse DRG neurons
released significantly more CGRP upon stimulation with eugenol
(p < 0.0001; n = 7), capsaicin (p < 0.01; n = 11) and resiniferatoxin
(p < 0.01; n = 11) in 2D (Fig. 2F) and capsaicin (p < 0.0001;
n = 21), resiniferatoxin (p < 0.0001; n = 6) and KCl (p < 0.0001;
n = 7) in 3D (Fig. 2H).
The capacity of capsaicin to induce an action potential in iPSC-
derived neurons was confirmed by the quantification of calcium
entry into cells upon stimulation. Five seconds after addition of
10 mM of capsaicin in the culture medium, an increase by 30% of
the relative fluorescence intensity was observed in iPSC-derived
neurons compared to the non-stimulated condition, which went
Fig. 1. Characterization by immunofluorescence of iPSC-derived neurons cultured in 2D and in 3D. Cells were stained by immunofluorescence for POU class 4 homeobox 1
(BRN3A), Neuronal Class III b-Tubulin (b3Tub), substance P (SP), tropomyosin receptor kinase A (TRKA), transient receptor potential cation channel member A1 (TRPA1),
neurofilament medium (NFM), transient receptor potential cation channel subfamily V1 (TRPV1) and receptor activity modifying protein 1 (RAMP1). For 2D staining (A,C,E,G),
cells were seeded at a density of 300,000 cells/cm2 on poly-D-lysine coated wells and matured until day 18. For 3D staining (B,D,F,H-J), neurons were cultured in the
fibroblast-populated sponge for 19 days and pictures were taken from an above view of the sponge. Scale bar A-H = 20 mm, I-J = 100 mm.
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Fig. 2. Quantification of SP and CGRP release from iPSC-derived and mouse DRG neurons upon TRP stimulation. Substance P (SP; A-D) and calcitonin gene-related peptide
(CGRP; E-H) released from iPSC-derived neurons (used after 19 days of maturation) (A,C,E,G) or mouse DRG neurons (B,D,F,H) were quantified by ELISA after stimulation with
65 nM potassium chloride (KCl, induces neuronal depolarization), 10 mM capsaicin (CAP, ligand for TRPV1), 100 nM resiniferatoxin (RES, ligand for TRPV1), 1 mM eugenol
(EUG, ligand for TRPV1,2,3) (except in D,H), 100 mM allyl isiothiocyanate (AITC, ligand for TRPA1), 100 ng/ml NGF (ligand for TrkA) cultured in monolayer (2D) or after seeding
in a fibroblast-populated sponge (3D). Data are displayed as mean ± standard error of the mean (*p < 0.01; **p < 0.001; ***p < 0.0001, n = 5 to 21).
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Fig. 3. Characterization by immunofluorescence of iPSC-derived Schwann cells cultured in 2D. Human iPSC-derived Schwann cells (A-D) or mouse Schwann cells (E-H) were
stained in 2D with the specific markers S100 (in red; A,E), GFAP (in green; B,F), P75 (in green; C,G) and SOX10 (in red; C,G). Schwann cells derived from iPSC (stained in white
with GFAP) were cocultured with iPSC-derived neurons (stained in green with NFM) for 18 days (D,H). Scale bar = 20 mm. (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)
Q. Muller et al. / Acta Biomaterialia 82 (2018) 93–101 99back to initial values after 5 s (Supplemental Fig. S4). The fibrob-
lasts used to generate iPSC did not show any increase in calcium
upon capsaicin stimulation (Data not shown).3.3. Efficient neurite outgrowth from iPSC-derived neurons throughout
the tissue-engineered skin is dependent on the presence of mouse or
iPSC-derived Schwann cells
When iPSC-derived neurons were cultured in the tissue-
engineered skin model, they failed to promote axonal outgrowth
from the neuronal cell layer at the bottom of the tissue to the epi-
dermis on top as observed with mouse DRG neurons (Fig. 4B vs A).
One major difference with DRG neurons that could explain this
limitation is the presence of Schwann cells that are extracted from
DRG along with neurons. Thus, we hypothesized that Schwann
cells might be an essential partner to promote axonal outgrowth.
Indeed, when mouse Schwann cells were added in the tissue-
engineered skin model prior to iPSC-derived neuron seeding, a
much higher neurite outgrowth was observed in the tissue with
numerous axons reaching the epidermis (Fig. 4C).
In order to develop a fully human model, the same iPSC used to
generate neurons were differentiated into human Schwann cells.
The resulting human iPSC-derived Schwann cells expressed the
specific markers S100, GFAP, p75 and SOX10 (Fig. 3). When these
cells were added in a 2D culture of iPSC-derived neurons, they
aligned along the neurites as observed with mouse Schwann cells
(Fig. 3D vs H). When the iPSC-derived Schwann cells were added
in the dermal compartment of the tissue-engineered skin model
before seeding and at the opposite side versus neurons, they were
shown to induce a strong increase in axonal outgrowth toward the
epidermis (Fig. 4D).4. Discussion
The aim of this work was to generate human iPSC-derived sen-
sory neurons to be used in place of rodent neurons to prepare
innervated tissue-engineered skin models. The animal origin of
neurons in these models does not seem to critically compromise
their ability to interact with most human skin cells, notablybecause neuropeptides are highly conserved among species. How-
ever, interspecies differences cannot be ruled out. Finally, the use
of animal cells has been banned in the European Union for cos-
metic research and development. Therefore, the replacement of
animal neurons by human neurons remains highly desirable.
Since the advent of the iPSC technology, several protocols have
been proposed to differentiate human sensory neurons from iPSC,
but with some limitations, such as low neuron differentiation effi-
ciency and low cell yields [7–14]. Moreover, none of these studies
have unequivocally demonstrated the ability of these neurons to
secrete neuropeptides following specific stimulations. Our purpose
was to generate sensory neurons from human skin fibroblast-
derived iPSC with high purity, high yield, and to demonstrate their
capacity to release SP and CGRP upon stimulation of their TRP
receptors.
In addition, we showed that these iPSC-derived neurons could
be efficiently integrated into a 3D tissue-engineered skin model.
Interestingly, this culture system created a favorable environment
for prolonged neuronal culture (49 days vs. 21 days in 2D), thereby
allowing the neurons to reach a higher maturation stage in 3D
while maintaining their capacity to release neuropeptides upon
stimulation. Moreover, a key feature of a functional innervated
tissue-engineered skin model is the ability of neurites extending
from neurons seeded at the bottom of the tissue to migrate
through the dermal compartment and form a nerve network
reaching the epidermis. Indeed, a direct contact of neurites with
keratinocytes is essential to efficiently recapitulate skin phys-
iopathology. A key finding of our work is the demonstration that
a coculture of iPSC-derived neurons with Schwann cells was neces-
sary to induce a strong neurite outgrowth in 3D. Of note, human
Schwann cells differentiated from the same iPSC used to generate
neurons were able to support such neurite outgrowth to maintain
a fully human model. It represents a promising method for gener-
ate a fully human innervated tissue-engineered skin model from
the biopsy of a single individual.
We intend to develop disease-specific skin models and analyze
the potential effect of sensory nerves in these models after induc-
tion of neuropeptide release upon stimulation with TRPV1 ago-
nists. Such model would be particularly well-suited for the
modelling of psoriasis, since this disease is highly suspected to
Fig. 4. Characterization by immunofluorescence of the capacity of the iPSC-derived neurons to form a 3D nerve network in the tissue-engineered skin. The human
reconstructed skin model made of keratinocytes (stained in green with Keratin 14), fibroblasts and mouse (A) or iPSC-derived (B-D) neurons (stained in red with b3Tub) was
cocultured or not (B) with mouse (C) or iPSC-derived Schwann cells (D). Scale bar = 50 mm. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
100 Q. Muller et al. / Acta Biomaterialia 82 (2018) 93–101be modulated by skin innervation [27,28]. It represents an optimal
base to build an immunocompetent skin model, with a strong
potential for personalized medicine approaches.
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Figure	S1│	Characterization	of	the	kinetic	of	neuronal	marker	expression	in	iPSC-derived	neurons	
over	22	days	of	maturation,	compared	with	mouse	DRG	neurons	
BRN3A,	Neurofilament	M	(NFM)	and	TRPV1	were	stained	with	specific	antibodies	after	12	to	22	days	
of	iPSC	differentiation	into	sensory	neurons	(A-O)	compared	to	mouse	DRG	neurons	(P-R).	Scale	bar:	
50	µm.	
	
	
Figure	S2│	Quantification	by	immunocytochemistry	of	BRN3A/βIII	Tubulin-positive	iPSC-derived	
neurons	
The	proportion	of	iPSC	successfully	differentiated	into	neurons	was	assessed	after	staining	with	
BRN3A	(B,	in	green)	and	βIII	Tubulin	(C,	in	red)	compared	to	the	total	numer	of	Dapi-positive	cells	(A,	
in	blue)	of	cells	cultured	for	18	days	in	24-well	plates	coated	with	poly-D-lysine.	The	white	arrows	in	A	
indicates	cells	that	don’t	express	the	neuronal	markers	in	B	and	C.	C	is	a	merge	image	of	A	and	B	in	
addition	to	βIII	Tubulin	staining.	Scale	bar	in	C	=	20	µm.	
	
	
	
	
Figure	S3│	Characterization	by	immunofluorescence	of	the	expression	of	Substance	P	in	
neurofilament	H-positive	iPSC-derived	neurons	cultured	in	3D	for	49	days	
The	iPSC-derived	neurons	were	cultured	in	the	fibroblast-populated	sponge	for	49	days	and	pictures	
were	taken	from	an	above	view.	Most	of	the	NFH-positive	nerve	fibers	(in	green	in	A	and	C)	expressed	
by	iPSC-derived	neurons	were	also	positive	for	SP	(in	red	in	B	and	C).	Scale	bar	200	µm.	
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Figure	S4│	Characterisation	of	iPSC-derived	neuron	excitability	upon	TRPV1	agonist	stimulation	by	
calcium	quantification	with	Fura-2	
Calcium	 flux	was	determined	according	 to	 the	manufacturer’s	 instructions	 (Fura-2	no	wash	calcium	
assay	kit,	Abcam).	Quantification	of	the	Fura-2	ratiometric	dye	fluorescence	 induced	by	 intracellular	
calcium	content	was	performed	using	a	Varioskan	microplate	reader	(Thermo	scientific)	before	and	5	
and	10	seconds	after	stimulation	with	10	µM	capsaicin	of	iPSC-derived	neurons	matured	for	19	days.	
Results	were	expressed	as	the	percentage	of	the	relative	fluorescence	intensity	(RFI)	obtained	with	the	
capsaicin	 treatment	compared	to	the	RFI	obtained	with	an	 incubation	of	 the	same	sample	with	the	
vehicle	(100µl	DME	with	0.99%	ethanol	vol:vol).	No	calcium	increase	was	observed	when	fibroblasts	
were	stimulated	with	10	µM	capsaicin	(data	not	shown).	Data	were	expressed	in	relative	fluorescence	
units	(RFI)		as	mean	±	standard	deviation	(*p<0.0001,	n=6).	
	
	
